Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy.
Gry Assam TaarnhøjHenriette LindbergChristoffer JohansenHelle PappotPublished in: Journal of patient-reported outcomes (2019)
The selection of disease specific PROs in a bladder cancer population was feasible. The process revealed several steps of selection needed in order to reach a final module for clinical application.